Evidence map›Paper›PMID 36645448›Full record

ArticleArchives of toxicology2023

A walk in the PARC: developing and implementing 21st century chemical risk assessment in Europe.

P Marx-Stoelting, G Rivière, M Luijten, K Aiello-Holden, N Bandow, K Baken, A Cañas, A Castano, S Denys, C Fillol and 22 more

Abstract readLetter
In one paragraph

Article in Archives of toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. ARACRA: Automated RNA-seq Analysis for Chemical Risk Assessment.Computational and structural biotechnology journal · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

P Marx-Stoelting *German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany. philip.marx-stoelting@bfr.bund.de.ORCID 0000-0002-6487-2153
G Rivière *French Agency for Food, Environmental and Occupational Health and Safety (ANSES), 94701, Maisons-Alfort, France.
M Luijten *National Institute for Health and Environment (RIVM), Bilthoven, The Netherlands.
K Aiello-Holden *German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.
N Bandow *German Environment Agency (UBA), Wörlitzer Platz 1, 06844, Dessau, Germany.
K Baken *VITO (Flemish Institute for Technological Research), Boeretang 200, 2400, Mol, Belgium.
A Cañas *National Centre for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
A Castano *National Centre for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
S Denys *Santé Publique France (SpFrance), 12, Rue du Val D'Osne, 94415, St. Maurice, France.
C Fillol *Santé Publique France (SpFrance), 12, Rue du Val D'Osne, 94415, St. Maurice, France.
M Herzler *German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.
I Iavicoli *Department of Public Health, University of Naples Federico II (UNINA), Naples, Italy.
S Karakitsios *Aristoteles University Thessaloniki (AUTH), Thessaloniki, Greece.
J Klanova *Masaryk Uinversity, Recetox, Kotlarska 2, 61137, Brno, Czechia.
M Kolossa-Gehring *German Environment Agency (UBA), Wörlitzer Platz 1, 06844, Dessau, Germany.
A Koutsodimou *General Chemical State Laboratory of Greece, Athens, Greece.
J Lobo Vicente *European Environment Agency, Kongens Nytorv 6, 1050, Copenhagen K, Denmark.
I Lynch *School of Geography, Earth and Environmental Sciences, University of Birmingham (UoB), Edgbaston, Birmingham, B15 2TT, UK.
S Namorado *National Institute of Health Dr. Ricardo Jorge (INSA), Avenida Padre Cruz, 1649-016, Lisbon, Portugal.
S Norager *European Commission, DG Research and Innovation, Orban 09/199, 1049, Brussels, Belgium.
A Pittman *French Agency for Food, Environmental and Occupational Health and Safety (ANSES), 94701, Maisons-Alfort, France.
S Rotter *German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.
D Sarigiannis *Aristoteles University Thessaloniki (AUTH), Thessaloniki, Greece.
M J Silva *National Institute of Health Dr. Ricardo Jorge (INSA), Avenida Padre Cruz, 1649-016, Lisbon, Portugal.
J Theunis *VITO (Flemish Institute for Technological Research), Boeretang 200, 2400, Mol, Belgium.
T Tralau *German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.
M Uhl *Austrian Federal Environments Agency, Vienna, Austria.
J van Klaveren *National Institute for Health and Environment (RIVM), Bilthoven, The Netherlands.
L Wendt-Rasch *Swedish Chemicals Agency (KemI), Vasagatan 12D, 172 67, Sundbyberg, Sweden.
E Westerholm *Swedish Chemicals Agency (KemI), Vasagatan 12D, 172 67, Sundbyberg, Sweden.
C Rousselle *French Agency for Food, Environmental and Occupational Health and Safety (ANSES), 94701, Maisons-Alfort, France.
P Sanders *French Agency for Food, Environmental and Occupational Health and Safety (ANSES), 94701, Maisons-Alfort, France.

Funding

European Commission 101057014
6 · The paper itself

Abstract

Current approaches for the assessment of environmental and human health risks due to exposure to chemical substances have served their purpose reasonably well. Nevertheless, the systems in place for different uses of chemicals are faced with various challenges, ranging from a growing number of chemicals to changes in the types of chemicals and materials produced. This has triggered global awareness of the need for a paradigm shift, which in turn has led to the publication of new concepts for chemical risk assessment and explorations of how to translate these concepts into pragmatic approaches. As a result, next-generation risk assessment (NGRA) is generally seen as the way forward. However, incorporating new scientific insights and innovative approaches into hazard and exposure assessments in such a way that regulatory needs are adequately met has appeared to be challenging. The European Partnership for the Assessment of Risks from Chemicals (PARC) has been designed to address various challenges associated with innovating chemical risk assessment. Its overall goal is to consolidate and strengthen the European research and innovation capacity for chemical risk assessment to protect human health and the environment. With around 200 participating organisations from all over Europe, including three European agencies, and a total budget of over 400 million euro, PARC is one of the largest projects of its kind. It has a duration of seven years and is coordinated by ANSES, the French Agency for Food, Environmental and Occupational Health & Safety.

Indexed as

Risk AssessmentEuropeHumansChemicalsExposure assessmentHazard characterisationHuman biomonitoring (HBM)New approach methods (NAM)Next-generation risk assessment (NGRA)Safety assessment

Identifiers

PMID36645448
PMCPMC9968685

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.